FCVFF yields 10.76% · JNJ yields 2.14%● Live data
📍 FCVFF pulled ahead of the other in Year 1
Combined, FCVFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FCVFF + JNJ for your $10,000?
F.C.C. Co., Ltd. manufactures and sells clutches, facings, and catalysts for automobiles, motorcycles, and general-purpose machinery in Japan and internationally. Its clutches for motorcycles comprise wet-type multi-disc, wet-type multi-disc assisted and slipper, wet-type and dry centrifugal, and racing clutches, as well as pulleys for belt converters for use in motorcycles, scooters, road sports bikes, ATVs, and racing vehicles. The company's automobiles clutches include automatic transmission, CVT, torque converter lockup, manual transmission, and 4WD vehicle clutches. In addition, its general-purpose clutches consist of FCCTRAC, a cam-type torque-sensitive limited slip differential for four-wheel ATVs; and hydraulic static transmissions for snow throwers and lawn mowers. The company was formerly known as Fuji Chemical Co., Ltd. and changed its name to F.C.C. Co., Ltd. in July 1984. F.C.C. Co., Ltd. was incorporated in 1939 and is headquartered in Hamamatsu, Japan.
Full FCVFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.